Medication info
Rabeton Tablet 10 mg (Rabeprazole Sodium)

Rabeton Tablet 10 mg (Rabeprazole Sodium)

Prescription medicationTablet경구
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
안국약품(주)
Appearance
Yellowish round film-coated tablets for enteric release
Packaging
28 tablets (14 tablets/Alu Alu packaging X2)
Approval status
Active

MFDS item code 200611006 · Notified 2006.11.20 · Insurance code 650200320

Summary

Main use
Treatment of gastric ulcer and duodenal ulcer, alleviation of symptoms of gastroesophageal reflux disease and maintenance therapy effect
Who takes it
Adults
Adult dose
For gastric ulcer and duodenal ulcer: typically, in adults, 10 mg of rabeprazole sodium is administered orally once a day. Depending on the symptoms, 20 mg can be administered orally once daily. Generally, treatment lasts for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. For erosive or ulcerative gastroesophageal reflux disease: 10 mg or 20 mg is given orally once daily for 4 to 8 weeks. If symptoms do not resolve after 8 weeks of PPI treatment, further treatment may need to be considered. For symptom relief of gastroesophageal reflux disease: administer 10 mg once a day. If symptoms are not controlled after 4 weeks, further examination will be required. Once symptoms resolve, on-demand therapy with 10 mg once daily can be utilized for any symptoms that arise thereafter. For long-term maintenance therapy of gastroesophageal reflux disease: administer 10 mg or 20 mg orally once daily, depending on the patient. For Helicobacter pylori eradication: Patients infected with Helicobacter pylori should undergo eradication therapy. It is recommended to use this medication 20 mg along with clarithromycin 500 mg and amoxicillin 1 g, administered twice daily for 7 days. For Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dosage may be adjusted up to 120 mg once daily depending on individual patient needs. Dosing can be done once daily for doses up to 100 mg, and for 120 mg it should be divided into two doses of 60 mg each. Patients with Zollinger-Ellison syndrome have been treated with this medication for up to a year. - For patients with liver impairment: Adverse reactions related to hepatic encephalopathy have been reported in cirrhotic patients. Therefore, caution is warranted in administration. - For children: Safety and effectiveness in children have not been established. - For the elderly: Caution is needed as they often have impaired liver function.

Ingredients

Manufacturer
안국약품(주)

Efficacy & effects

Treatment of gastric ulcer and duodenal ulcer, alleviation of symptoms of gastroesophageal reflux disease and maintenance therapy effect

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • gastrointestinal ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication treats gastric ulcers and duodenal ulcers and helps alleviate the symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also used for long-term maintenance therapy of gastroesophageal reflux disease and is administered in combination with antibiotics for gastrointestinal ulcer patients infected with Helicobacter pylori. It is effective for Zollinger-Ellison syndrome as well. It is used for the treatment and symptom relief of various gastrointestinal disorders.

How to take

Adult dose

For gastric ulcer and duodenal ulcer: typically, in adults, 10 mg of rabeprazole sodium is administered orally once a day. Depending on the symptoms, 20 mg can be administered orally once daily. Generally, treatment lasts for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. For erosive or ulcerative gastroesophageal reflux disease: 10 mg or 20 mg is given orally once daily for 4 to 8 weeks. If symptoms do not resolve after 8 weeks of PPI treatment, further treatment may need to be considered. For symptom relief of gastroesophageal reflux disease: administer 10 mg once a day. If symptoms are not controlled after 4 weeks, further examination will be required. Once symptoms resolve, on-demand therapy with 10 mg once daily can be utilized for any symptoms that arise thereafter. For long-term maintenance therapy of gastroesophageal reflux disease: administer 10 mg or 20 mg orally once daily, depending on the patient. For Helicobacter pylori eradication: Patients infected with Helicobacter pylori should undergo eradication therapy. It is recommended to use this medication 20 mg along with clarithromycin 500 mg and amoxicillin 1 g, administered twice daily for 7 days. For Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dosage may be adjusted up to 120 mg once daily depending on individual patient needs. Dosing can be done once daily for doses up to 100 mg, and for 120 mg it should be divided into two doses of 60 mg each. Patients with Zollinger-Ellison syndrome have been treated with this medication for up to a year. - For patients with liver impairment: Adverse reactions related to hepatic encephalopathy have been reported in cirrhotic patients. Therefore, caution is warranted in administration. - For children: Safety and effectiveness in children have not been established. - For the elderly: Caution is needed as they often have impaired liver function.

Precautions

This medication should not be used in patients who are allergic to specific ingredients or who have had hypersensitivity reactions to benzimidazoles. Furthermore, it should not be administered to patients allergic to amoxicillin or clarithromycin when used in combination during Helicobacter pylori eradication therapy. Caution is necessary when taken with specific cardiac-related medications as side effects may occur. It is safest for pregnant or breastfeeding women to avoid using this medication. Patients with impaired liver function or the elderly should use this drug carefully, and caution is required in those with a history of hypersensitivity to the drug. If allergic symptoms such as rash or itching occur during use, the medication should be discontinued immediately. Routine blood tests and liver function tests should be performed, and appropriate action should be taken if abnormalities are found. Various side effects may occur in the cardiovascular, gastrointestinal, neurological, respiratory, musculoskeletal, skin, eye, and urinary systems, hence symptoms should be observed carefully. Prolonged use may increase the risk of fractures and result in hypomagnesemia, so regular monitoring and supplementation may be needed. This medication suppresses gastric acid secretion, which may increase the risk of gastrointestinal bacterial infections; if diarrhea persists, consultation with a medical professional is advised. Caution is advised as drowsiness may pose a risk during driving or operating machinery. Interactions with other medications may occur, so it is essential to inform the healthcare provider of any concurrent medications. In case of overdose, there is no specific antidote, and treatment should focus on symptoms and supportive measures. This medication should not be chewed or crushed and must be swallowed whole, and it should be kept out of reach of children. It is essential to consult a healthcare professional if any unusual symptoms or suspected side effects occur.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling, chest tightness, difficulty breathing, cold sweat, paleness, severe rash accompanied by high fever, blisters, skin peeling, pain in mouth/eye mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, yellowing of skin or eyes, severe lassitude, sudden and severe headaches, lightning-like headache, seizures, confusion, visual disturbances, paralysis, significantly reduced urine output,

Mild side effects

  • Rash
  • itching
  • decreased red blood cells
  • decreased white blood cells
  • increased white blood cells
  • increased eosinophils
  • increased neutrophils
  • decreased lymphocytes
  • anemia
  • petechiae
Show 19 more
  • lymphadenopathy
  • hypochromic anemia
  • pancytopenia
  • agranulocytosis
  • decreased platelets
  • hemolytic anemia
  • increased ALT
  • increased AST
  • increased ALP
  • increased γ-GTP
  • increased LDH
  • elevated total bilirubin
  • hypertension
  • myocardial infarction
  • ECG abnormalities
  • migraine
  • syncope
  • angina
  • heart palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to prevent exposure to air or moisture and should be stored at room temperature, between 1 to 30 degrees Celsius. This will help maintain the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Yellowish round film-coated tablets for enteric release

Package unit

28 tablets (14 tablets/Alu Alu packaging X2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.